We are live on ! Find out more
INVA icon

Innoviva

235 hedge funds and large institutions have $1.24B invested in Innoviva in 2024 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 96 increasing their positions, 62 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,479% more call options, than puts

Call options by funds: $921K | Put options by funds: $14K

67% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 21

55% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 62

6% more funds holding

Funds holding: 221235 (+14)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

2.51% less ownership

Funds ownership: 116.26%113.75% (-2.5%)

12% less capital invested

Capital invested by funds: $1.41B → $1.24B (-$173M)

Holders
235
Holders Change
+14
Holders Change %
+6.33%
% of All Funds
3.1%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
35
Increased
96
Reduced
62
Closed
21
Calls
$921K
Puts
$14K
Net Calls
+$907K
Net Calls Change
+$141K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$165M +$1.91M +99,401 +1%
SCM
2
Sarissa Capital Management
Connecticut
$126M
Vanguard Group
3
Vanguard Group
Pennsylvania
$110M +$1.63M +84,934 +1%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$85.4M +$4.35M +226,592 +5%
Franklin Resources
5
Franklin Resources
California
$76.9M -$44.4M -2,312,744 -34%
Renaissance Technologies
6
Renaissance Technologies
New York
$73.9M -$1.31M -68,175 -2%
Pacer Advisors
7
Pacer Advisors
Pennsylvania
$50.9M +$2.33M +121,162 +4%
State Street
8
State Street
Massachusetts
$42.7M +$154K +8,036 +0.3%
SFM
9
Systematic Financial Management
New Jersey
$35.2M +$960K +49,996 +3%
Goldman Sachs
10
Goldman Sachs
New York
$30.2M +$11.1M +579,904 +50%
American Century Companies
11
American Century Companies
Missouri
$24.7M +$7.12M +370,795 +35%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$23.6M -$8.08K -421 -0%
Arrowstreet Capital
13
Arrowstreet Capital
Massachusetts
$19.9M +$1.56M +81,142 +8%
Morgan Stanley
14
Morgan Stanley
New York
$18.9M +$1.65M +86,180 +9%
Bank of America
15
Bank of America
North Carolina
$18.5M -$1.24M -64,713 -6%
Invesco
16
Invesco
Georgia
$18.3M -$7.66M -398,882 -27%
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$14.6M +$3.54M +184,595 +28%
Deutsche Bank
18
Deutsche Bank
Germany
$14.6M -$165K -8,574 -1%
Northern Trust
19
Northern Trust
Illinois
$11.8M +$507K +26,429 +4%
UBS Group
20
UBS Group
Switzerland
$11.7M +$7.07M +368,123 +119%
Charles Schwab
21
Charles Schwab
California
$10.9M -$2.01M -104,634 -14%
Boston Partners
22
Boston Partners
Massachusetts
$8.51M +$2.86M +149,060 +44%
Qube Research & Technologies (QRT)
23
Qube Research & Technologies (QRT)
United Kingdom
$8.5M +$9.19M +478,511 +4,225%
Man Group
24
Man Group
United Kingdom
$8.45M +$1.57M +81,891 +20%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$7.82M +$15.5K +807 +0.2%

INVA Hedge Fund Activity: Q4 2024 in Review

235 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q4 2024, worth a combined $1.24B — down 12% from $1.41B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new INVA positions and 21 closed out — a net gain of 14 holders — while 96 added to existing stakes and 62 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $11.1M. The largest seller was Franklin Resources, cutting an estimated $44.4M.

  • 235 institutional investors held Innoviva (INVA) as of Q4 2024, up from 221 in Q3 2024.
  • Funds reported $1.24B of Innoviva stock for Q4 2024, down 12% quarter-over-quarter.
  • 35 funds opened new Innoviva positions in Q4 2024 and 21 closed out, a net change of +14 holders.
  • The largest Innoviva buyer in Q4 2024 was Goldman Sachs, an estimated $11.1M added.
  • The largest Innoviva seller in Q4 2024 was Franklin Resources, an estimated $44.4M sold.

Based on aggregated 13F filings for Q4 2024.